Table 5 Management
| Â | Total population | Alexandria | Cairo | Delta | Upper Egypt | P value |
|---|---|---|---|---|---|---|
Number of patients | 1645 | 914 | 249 | 409 | 73 | Â |
ACEi, % | 76.4 | 79.6 | 57.4 | 79.2 | 79.3 | < 0.0001 |
ARB, % | 10.1 | 8.5 | 15.5 | 11.5 | 3.5 | 0.1 |
ACEi/ARB, % | 86.5 | 88.1 | 72.9 | 90.7 | 82.2 | < 0.0001 |
BB, % | 64.0 | 70.1 | 53.7 | 55.4 | 71.4 | < 0.0001 |
MRA, % (if indicated) | 78.7 | 71.4 | 82.4 | 88.0 | 90.0 | 0.0002 |
Diuretics, % | 76.6 | 71.2 | 78.0 | 86.0 | 85.7 | < 0.0001 |
CCB, % | 8.3 | 10.5 | 6.1 | 4.7 | 8.8 | 0.003 |
Nitrites, % | 50.5 | 57.9 | 34.9 | 48.0 | 12.3 | < 0.0001 |
Digitalis, % | 36.1 | 25.5 | 47.9 | 52.2 | 38.6 | < 0.0001 |
Amiodarone, % | 11.3 | 8.3 | 13.0 | 15.8 | 11.3 | 0.0002 |
Ivabradine, % | 7.1 | 3.0 | 10.7 | 12.8 | 15.8 | < 0.0001 |
Statins, % | 70.5 | 80.6 | 50.5 | 65.0 | 31.6 | < 0.0001 |
Anti-platlets, % | 78.5 | 85.6 | 65.4 | 74.5 | 49.1 | < 0.0001 |
Anti-coagulants, % | 32.7 | 23.7 | 39.5 | 49.0 | 29.8 | < 0.0001 |
Cardiac devices utilization | ||||||
 CRT indicated, % | 14.0 | 17.5 | 8.2 | 11.3 | 1.5 | < 0.0001 |
 CRT planned, % | 2.5 | 1.0 | 2.7 | 3.7 | 1.5 | 0.08 |
 ICD indicated, % | 6.6 | 5.2 | 9.1 | 9.3 | 0.0 | < 0.0001 |
 ICD planned % | 1.5 | 0.1 | 2.4 | 2.4 | 0.0 | 0.65 |